Not Found
Digital Seminar

GI Pharmacology Update: Prescribing for Patient Outcome Achievement


Faculty:
Peter Buch, MD, AGAF, FACP
Duration:
2 Hours 30 Minutes
Format:
Audio and Video
Copyright:
Jun 30, 2021
Product Code:
POS078420
Media Type:
Digital Seminar


Description

  • How do we choose the “best treatment” for Eosinophilic Esophagitis? 
  • Why are there so many recurrences of Helicobacter pylori? 
  • What are the best options for treating C. difficile? 

Please join Clinical Gastroenterologist Dr. Peter Buch as he explores the answers to these and many other questions in this advanced, case-based, and evidence-supported training event.  At the end of this session, you will have new knowledge on the best pharmacologic practices for the most common GI concerns seen in practice. 

Credits


**

NOTE: Tuition includes one free CE Certificate (participant will be able to print the certificate of completion after completing and passing the on-line post-test evaluation). 

Continuing Education Information:  Listed below are the continuing education credit(s) currently available for this non-interactive self-study package. Please note, your state licensing board dictates whether self-study is an acceptable form of continuing education. Please refer to your state rules and regulations. If your profession is not listed, please contact your licensing board to determine your continuing education requirements and check for reciprocal approval. For other credit inquiries not specified below, please contact cepesi@pesi.com or 800-844-8260 before the event.

Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of your profession.  As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your profession's standards.  

All members of the PESI, Inc. planning committee have provided disclosures of financial relationships with ineligible organizations and any relevant non-financial relationships prior to planning content for this activity. None of the committee members had relevant financial relationships with ineligible companies or other potentially biasing relationships to disclose to learners.  For speaker disclosures, please see the faculty biography.


Pharmacology Nurse Practitioners

This self-study program offers 150 instructional minutes of pharmacology content which is designed to qualify for 2.5 contact hours toward your pharmacology requirement. 


Nurses, Nurse Practitioners, and Clinical Nurse Specialists

PESI, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses completing these self-study materials will earn 2.5 contact hours. Expires: 06/30/2024.


California Nurses

PESI, Inc. is a provider approved by the California Board of  Registered Nursing, Provider #: 17118 for 2.5 self-study contact hours. 

** You will need to provide your license number to PESI. PESI must have this number on file in order for your hours to be valid.


Florida Nurses

PESI, Inc. is an approved provider by the Florida Board of  Nursing. Provider #: FBN2858. These materials qualify for 2.5 self-study contact hours.

CE Broker


Iowa Nurses

PESI, Inc. is an approved provider by the Iowa Board of Nursing. Provider #: 346. Nurses successfully completing these self-study materials will earn 2.5 self-study contact hours. Please email cepesi@pesi.com with your license number, include the title, speaker name and date. PESI must have this number on file in order for your hours to be valid.


Physician Assistants

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME such as PESI. Physician assistants may receive a maximum of 2.5 hours for completing this self-study program. This activity was originally recorded on 06/30/2021. It was last reviewed on 10/17/2021 and is valid until 10/17/2024. 

 

PESI, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. PESI, Inc. designates this enduring material for a maximum of 2.5 AMA PRA Category 1 Credit(s)™.


Other Professions

This self-study activity qualifies for 2.5 continuing education clock hours as required by many national, state and local licensing boards and professional organizations. Save your activity advertisement and certificate of completion, and contact your own board or organization for specific requirements.



Handouts/Brochure

Faculty

Peter Buch, MD, AGAF, FACP Related seminars and products


Peter Buch, MD, AGAF, FACP, is a clinical gastroenterologist with over 30 years of specialty experience to draw from. His current practice is in Manchester, Connecticut where he has assembled a team that treats all GI conditions. "We pride ourselves in giving each patient the time and care they need," says Dr Buch. This has resulted in outstanding patient evaluations and much better outcomes.

Dr. Buch has a passion for teaching. His style is case based, practical, very interactive and evidence supported. Dr. Buch's expertise has been shared with experienced clinicians and advanced level students. He teaches at the University of Connecticut School of Medicine, the University of New England College of Osteopathic Medicine, the Frank H Netter School of Medicine/Quinnipiac University and the University of Connecticut APRN School.

Speaker Disclosures: 
Financial: Peter Buch is an Associate Clinical Professor of Medicine at the University of Connecticut School of Medicine; and at the University of New England College of Osteopathic Medicine. He is an Association Professor at Frank H. Netter School of Medicine/Quinnipiac University. Dr. Buch receives a speaking honorarium from AbbVie Synergy Pharmaceuticals. Peter Buch receives a speaking honorarium from PESI, Inc. 
Non-financial: Peter Buch is a member of the American College of Gastroenterology where he serves on the FDA Committee and the Patient Care Committee. 

Content Disclosure: 
Dr. Buch references the use of antidepressants for Irritable Bowel Syndrome; and the controversial use of Fibrotest to evaluate patients with fatty liver disease who may have fibrosis of the liver. Dr. Buch indicates he wishes to present a fair and balanced approach to practitioners regarding such practices.


Additional Info

Program Information

Access for Self-Study (Non-Interactive)

Access never expires for this product.


Questions?

Visit our FAQ page at www.pesi.com/faq or contact us at www.pesi.com/info


Objectives

  1. Determine the current best medication practices for inflammatory bowel disease. 
  2. Detect which medical conditions respond to probiotics. 
  3. Analyze the best pharmacological strategies for PPI use. 
  4. Explore important updates in clostridium difficile treatment. 
  5. Plan to incorporate the newest strategies for successful treatment of Irritable Bowel Syndrome.

Outline

Eosinophilic Esophagitis 
  • Proton pump inhibitor (PPI) use 
  • Swallowed steroids 
  • Elimination diet 
Helicobacter Pylori 
  • Testing regimens 
  • Clarithromycin resistance and need for quadruple therapy 
  • Pill burden and risk of recurrence 
  • How to manage refractory H pylori 
Proton pump inhibitors (PPIs) 
  • Who needs chronic therapy 
  • REAL side effects of PPIs 
Gastroparesis Diagnosis & Medication Choices 
  • Metoclopramide 
  • Erythromycin 
  • Symptomatic care 
Clostridium Difficile 
  • Should we still be using Metronidazole? 
  • Vancomycin 
  • Fidaxomicin 
  • Fecal transplants - the ultimate probiotic 
  • Bezlotoxumab 
Irritable Bowel Syndrome 
  • Are probiotics effective? 
  • OTC therapies 
  • Glutamine/Peppermint/Iberogast 
  • Antispasmodics 
  • Rifaximin 
  • Eluxadoline 
  • Lubiprostone/Linaclotide/Plecanitide/Prucalopride 
  • Antidepressants  
GI Bleeding    
  • When to use vitamin K and fresh frozen plasma  
  • When to reverse direct oral anticoagulants 
  • The management of GI bleeding and recent stent placement 
Inflammatory Bowel Disease 
  • When to consider 5 ASAs 
  • Antibiotics 
  • Steroids 
  • Antimetabolites 
  • Anti TNFs 
  • Vedolizumab 
  • Ustekinumab 
  • Tofacitiniub 
  • Biosimilars 
Opioid Induced Constipation 
  • How to choose among: Osmotic or stimulant laxatives 
  • PAMORAS: Naloxegol,Naldemedine, Methylnaltrexone 
  • Secretogogues like Lubiprostone 
  • Selective 5HT4 agonist like Prucalopride 
Liver Diseases 
  • Non-selective beta blockers to prevent variceal bleeding 
  • Statin use and the liver 
  • Acetaminophen safety in chronic liver disease 
  • Hepatitis C regimens 

Target Audience

  • Nurses
  • Nurse Practitioners
  • Clinical Nurse Specialists
  • Physician Assistants

Reviews

Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.

ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.

PESI Mobile App

Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of live webcasts and online courses from the world’s best instructors, and complete your CE requirements anywhere, anytime, at your own pace.

https://ce21.blob.core.windows.net/images/android.png     https://ce21.blob.core.windows.net/images/iphone.png

Please wait ...

Back to Top